and space exploration company SpaceX (SPACE), welcomed the FDA’s decision shortly after Neuralink announced the designation. “The Blindsight device from Neuralink will enable even those who ...
The US Food and Drug Administration (FDA) has awarded a "Breakthrough Device" status to Neuralink’s experimental vision-restoring implant, Blindsight. This designation is intended to fast-track ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results